Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Music lecturer’s innovative app is a first in South Africa
2014-07-24

Dr Frelét de Villiers, lecturer at the Odeion School of Music (OSM) at the University of the Free State (UFS), is in the process of developing an innovative interactive mobile music application – Notes&Fun.

Notes&Fun is being designed to assist aspirant pianists. It will support beginners with notation and rhythmic patterns.

The app will display single notes, phrases or rhythmical patterns on the phone or tablet and then apply the built-in microphone to measure the frequency of the notes played on the piano itself. It will indicate whether you’ve played correctly, or if you have made a mistake, the correct note will be displayed. Notes&Fun consists of multiple levels, each with a practise and test mode that gradually increases in difficulty and complexity. As opposed to existing apps, Notes&Fun is conceptualised with immediate pitch detection and is applied with a real (acoustic) piano.

For the pilot phase of this initiative, the developing company Maxxor in Cape Town will create a demo app which can be downloaded for testing purposes and general feedback. Once the developing company and innovator are satisfied with the first phase, the product will be marketed vigorously on social media. The initial app will be free, but subsequent levels will need to be purchased. The developers will start a Facebook page where users of the app can add their latest scores and compete with other users. Initially the app will only be available on the Google Play Store due to the fact that more people own Android devices than Apple products. Once the product has proven to be financially viable, the developers will adapt it for the Mac App Store as well.

“The beauty of this app is that music has a universal language, so it can be marketed internationally and I am privileged to have the institutional support from the UFS Technology Unit regarding the judicial process and developing process of the product,” Dr De Villiers said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept